Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
The medication is clearly doing something, just not producing weight loss anymore
Their dosing schedules vary by manufacturer and should always follow the specific product label
ATM/CHK2 - Ataxia Telangiectasia Mutated/Checkpoint Kinase 2
Pre-existing sleep issues
37 , e22729 (2023)
US$ 24.07
US$ 28.81
US$ 24.82
US$ 21.47
US$ 26.28
